Thoracic Cancer Research

Thoracic Cancer Research

Research into thoracic cancer at Penn State Cancer Institute is conducted by our dedicated thoracic cancer team. See current clinical trials and members of that team here.

Clinical Trials

Repository of Lung Cancer Diagnostic Procedure Images
Piloting a Virtual Navigation (VN) System for Bronchoscopic Tissue Sampling
MATCH Treatment Subprotocol A: Phase II Trial of Afatinib in Patients with Solid Tumors (Other Than Small Cell and Non-Small Cell Lung Cancer) or Lymphomas, That Have Activating Mutations of EGFR and Have Progressed After Standard Treatment
A Phase 1b/2 Study of ARRY-382 in Combination with Pembrolizumab, a Programmed Cell Death Receptor 1 (PD-1) Antibody, for the Treatment of Patients with Advanced Solid Tumors Cell Death Receptor 1 (PD-1) Antibody, for the Treatment of Patients with Advanced Solid Tumors
A Phase Ib/II Study of Anti-PD-1 Antibody Pembrolizumab and Imprime PGG for Patients With Metastatic Non-small Cell Lung Cancer After Progression on First-Line Chemotherapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017
AN OPEN-LABEL, MULTICENTER EXTENSION AND LONG-TERM OBSERVATIONAL STUDY IN PATIENTS PREVIOUSLY ENROLLED IN A GENENTECH- AND/OR F. HOFFMANN-LA ROCHE LTD- SPONSORED ATEZOLIZUMAB STUDY
Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab alone following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)
Children's Lives Include Moments of Bravery (CLIMB)
UGT Genes and Gender Differences In Lung Cancer Risk
Oncogenic Mutations/Gene Rearrangements in Patients with Advanced Adenocarcinoma Lung
Characterization of Oncogenic Mutations in Patients with Advanced Squamous Cell Lung Cancer
Oncogenic Driver Mutations/Biomarkers in Screening Participants for Early Detection of Lung Cancer
The Incidence of Granulomatous Inflammation and Metastatic Carcinoma via Transbronchial Needle Aspirate Sampling Methods
One Time Tissue and Blood Collection from Patients with Lung Cancer or at Risk for Developing Lung Cancer
The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
Tissue and Blood Collection from Patients with Suspected Lung Cancer
Morphologic, Immunohistochemical, Molecular, and Laboratory Analysis of Lung Diseases

Disease Team Members

First Name Last Name Title Role
Salah Almokadem Salah Almokadem View Profile
Ayodele Ayoola, MD Ayodele Ayoola MD View Profile
Rebecca Bascom, MD, MPH Rebecca Bascom MD, MPH View Profile
Chandra Belani, MD Chandra Belani MD View Profile
Rickhesvar Mahraj, MD, FRCP, FRCR Rickhesvar Mahraj MD, FRCP, FRCR View Profile
Michael F. Reed, MD Michael F. Reed MD View Profile
Marc Rovito, MD Marc Rovito MD View Profile
Matthew D. Taylor, MD Matthew D. Taylor MD View Profile
Jennifer Toth, MD Jennifer Toth MD View Profile
Leonard Tuanquin, MD Leonard Tuanquin MD View Profile
Henry Wagner Jr., MD Henry Wagner Jr. MD View Profile
Nicholas Zaorsky, MD Nicholas Zaorsky MD View Profile
Research into thoracic cancer at Penn State Cancer Institute is conducted by our dedicated thoracic cancer team. See current clinical trials and members of that team here.
Repository of Lung Cancer Diagnostic Procedure Images
Piloting a Virtual Navigation (VN) System for Bronchoscopic Tissue Sampling
MATCH Treatment Subprotocol A: Phase II Trial of Afatinib in Patients with Solid Tumors (Other Than Small Cell and Non-Small Cell Lung Cancer) or Lymphomas, That Have Activating Mutations of EGFR and Have Progressed After Standard Treatment
A Phase 1b/2 Study of ARRY-382 in Combination with Pembrolizumab, a Programmed Cell Death Receptor 1 (PD-1) Antibody, for the Treatment of Patients with Advanced Solid Tumors Cell Death Receptor 1 (PD-1) Antibody, for the Treatment of Patients with Advanced Solid Tumors
A Phase Ib/II Study of Anti-PD-1 Antibody Pembrolizumab and Imprime PGG for Patients With Metastatic Non-small Cell Lung Cancer After Progression on First-Line Chemotherapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017
AN OPEN-LABEL, MULTICENTER EXTENSION AND LONG-TERM OBSERVATIONAL STUDY IN PATIENTS PREVIOUSLY ENROLLED IN A GENENTECH- AND/OR F. HOFFMANN-LA ROCHE LTD- SPONSORED ATEZOLIZUMAB STUDY
Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab alone following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)
Children's Lives Include Moments of Bravery (CLIMB)
UGT Genes and Gender Differences In Lung Cancer Risk
Oncogenic Mutations/Gene Rearrangements in Patients with Advanced Adenocarcinoma Lung
Characterization of Oncogenic Mutations in Patients with Advanced Squamous Cell Lung Cancer
Oncogenic Driver Mutations/Biomarkers in Screening Participants for Early Detection of Lung Cancer
The Incidence of Granulomatous Inflammation and Metastatic Carcinoma via Transbronchial Needle Aspirate Sampling Methods
One Time Tissue and Blood Collection from Patients with Lung Cancer or at Risk for Developing Lung Cancer
The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
Tissue and Blood Collection from Patients with Suspected Lung Cancer
Morphologic, Immunohistochemical, Molecular, and Laboratory Analysis of Lung Diseases
First Name Last Name Title Role
Salah Almokadem Salah Almokadem View Profile
Ayodele Ayoola, MD Ayodele Ayoola MD View Profile
Rebecca Bascom, MD, MPH Rebecca Bascom MD, MPH View Profile
Chandra Belani, MD Chandra Belani MD View Profile
Rickhesvar Mahraj, MD, FRCP, FRCR Rickhesvar Mahraj MD, FRCP, FRCR View Profile
Michael F. Reed, MD Michael F. Reed MD View Profile
Marc Rovito, MD Marc Rovito MD View Profile
Matthew D. Taylor, MD Matthew D. Taylor MD View Profile
Jennifer Toth, MD Jennifer Toth MD View Profile
Leonard Tuanquin, MD Leonard Tuanquin MD View Profile
Henry Wagner Jr., MD Henry Wagner Jr. MD View Profile
Nicholas Zaorsky, MD Nicholas Zaorsky MD View Profile

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)